John Wofford, MD
Dermatopathology · Dallas, TXNPI 1245596451
Payments from drug & device makers
Across 393 payments — averaging $27.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Lilly USA, LLC$1K
- Amgen$900
- Johnson & Johnson$823
- Regeneron Healthcare Solutions, Inc.$635
- LEO Pharma Inc.$603
- plus $4K from 29 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 76 | $2,585 |
| Lilly USA, LLC | 47 | $1,184 |
| Amgen | 31 | $900 |
| Johnson & Johnson | 29 | $823 |
| Regeneron Healthcare Solutions, Inc. | 25 | $635 |
| LEO Pharma Inc. | 27 | $603 |
| E.r. Squibb & Sons, L.L.C. | 17 | $572 |
| Sun Pharmaceutical Industries Inc. | 20 | $556 |
| Sanofi | 15 | $426 |
| Galderma Laboratories, L.p. | 9 | $299 |
| Almirall LLC | 11 | $229 |
| UCB, Inc. | 10 | $224 |
| Incyte Corporation | 9 | $165 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 8 | $153 |
| Bristol Myers Squibb | 2 | $145 |
| Boehringer Ingelheim | 5 | $134 |
| Pfizer | 7 | $125 |
| Novartis | 5 | $113 |
| Mayne Pharma Commercial LLC | 8 | $110 |
| EPI Health, LLC | 5 | $107 |
| Arcutis Biotherapeutics, Inc. | 6 | $105 |
| Dermira, Inc. | 2 | $97 |
| Encore Dermatology Inc. | 4 | $81 |
| DUSA Pharmaceuticals, Inc. | 2 | $43 |
| VYNE Pharmaceuticals Inc. | 2 | $40 |
| Biofrontera Inc. | 2 | $38 |
| Merz North America, Inc. | 1 | $37 |
| Fidia Pharma USA Inc. | 1 | $25 |
| Dermavant Sciences, Inc. | 1 | $24 |
| Smith+Nephew | 1 | $22 |
| Kyowa Kirin, Inc. | 1 | $19 |
| Nabriva Therapeutics, PLC | 1 | $19 |
| Medimetriks Pharmaceuticals, Inc. | 1 | $18 |
| Genentech USA, Inc. | 1 | $18 |
| Botanix SB Inc | 1 | $14 |
How this compares
$10,691 in reported general payments places this provider in the 75th percentile of 54 dermatopathology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other dermatopathology in Dallas
- Clay CockerellDallas$40K
- Titilola SodeDallas$11K
- Gregory HoslerDallas$3K
- Joseph SusaDallas$470
- Robert LawDallas$68
- Ryan HickDallas$50
- Angela MooreArlington$9.5M
- Melissa ChiangSpring$250K
- Adaobi ObasiLaredo$126K
- Alde GavinoLiberty Hill$110K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.